Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Reply to: On gene silencing by the X10-23 DNAzyme

The Original Article was published on 18 July 2022

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Evaluation of the secondary structure of KRAS RNA variant b (NCBI reference sequence NM_004985.5).

Data availability

No new data were included in the response.


  1. Taylor, A. I. & Holliger, P. In vivo gene silencing by the modified X10-23 DNAzyme. Nat. Chem. (2022).

  2. Wang, Y., Nguyen, K., Spitale, R. C. & Chaput, J. C. A biologically stable DNAzyme that efficiently silences gene expression in cells. Nat. Chem. 13, 319–326 (2021).

    CAS  Article  Google Scholar 

  3. Nguyen, K., Wang, Y. J., England, W. E., Chaput, J. C. & Spitale, R. C. Allele-specific RNA knockdown with a biologically stable and catalytically efficient XNAzyme. J. Am. Chem. Soc. 143, 4519–4523 (2021).

    CAS  Article  Google Scholar 

  4. Young, D. D., Lively, M. O. & Deiters, A. Activation and deactivation of DNAzyme and antisense function with light for the photochemical regulation of gene expression in mammalian cells. J. Am. Chem. Soc. 132, 6183–6193 (2010).

    CAS  Article  Google Scholar 

  5. Rivory, L. et al. The DNAzymes Rs6, Dz13 and DzF have potent biologic effects independent of catalytic activity. Oligonucleotides 16, 297–312 (2006).

    CAS  Article  Google Scholar 

  6. Takahashi, M. et al. Dual mechanisms of action of self-delivering, anti-HIV-1 FANA oligonucleotides as a potential new approach to HIV therapy. Mol. Ther. Nucleic Acids 17, 615–625 (2019).

    CAS  Article  Google Scholar 

  7. Crooke, S. T. Antisense Drug Technology: Principles, Strategies and Applications 2nd edn (CRC Press, 2008).

    Google Scholar 

Download references


This work was supported by the W.M. Keck Foundation.

Author information

Authors and Affiliations



J.C.C. and R.C.S. wrote the response with input from K. Nguyen and Y. Wang. K.N. prepared the figure.

Corresponding author

Correspondence to John C. Chaput.

Ethics declarations

Competing interests

J.C.C. is a consultant for 1E Therapeutics. The work reported here occurred prior to this relationship. R.C.S. declares no competing interests.

Peer review

Peer review information

Nature Chemistry thanks Yingfu Li and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Spitale, R.C., Chaput, J.C. Reply to: On gene silencing by the X10-23 DNAzyme. Nat. Chem. 14, 859–861 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing